Search

Despite the potential influence of sex on delay-discounting rates, there is no previous evidence with regard to the effect of this variable on the clinical interventions aimed at modifying delay-discounting rates. This study assessed the effect of sex on the association between the type of treatment received (either cognitive-behavioral treatment [CBT] alone or combined with contingency management [CM + CBT]) and delay-discounting changes at end of treatment and 6-month follow-up. This aim was addressed after controlling for the influence of baseline delay discounting. Treatment-seeking smokers (N = 116) were randomly assigned to either CM + CBT (n = 69) or CBT alone (n = 47). Participants completed delay-discounting assessments at intake, at end of treatment, and at 6-month follow-up. Results showed that there was a significant interaction effect of treatment type and sex, such that women who received CM decreased their discounting more than women who did not. However, this effect was not found among men. Participants who discounted most at intake showed the greatest delay-discounting decreases. Lastly, smoking abstinence did not affect changes in delay discounting. The current results suggest that CM intervention may have a differential effect on delay-discounting changes as a function of sex. This finding supports the relevance of considering the effect of individual variables when assessing changes in delay discounting due to clinical interventions., ((c) 2015 APA, all rights reserved).)

Several studies examining both control and substance-dependent populations have found delay discounting to remain stable over time. In this report, we examine whether delay discounting changes in opioid-dependent individuals who complete a 12-week treatment. The 159 subjects who completed discounting assessments at baseline and treatment-end come from two separate clinical trials: 56 from Chopra et al. (2009) and 103 from Christensen et al. (2012). Mean discounting at 12 weeks significantly decreased to less than half (44.8%) of the baseline level (95% CIs (27.5, 73.2)). Analyzing each subject's discounting data individually, over 3 times (95% CIs (1.9, 5.5)) as many subjects statistically decreased their discounting from their own baseline levels than those who exhibited a statistical increase. Though we failed to find any relationship among discounting measures and abstinence outcomes, the results from this large study suggest that treatment for substance dependence promotes decreases in delay discounting.

The purpose of the current study was to identify predictors of delay discounting among adolescents receiving treatment for marijuana abuse or dependence, and to test delay discounting as a predictor of treatment outcome. Participants for this study were 165 adolescents (88% male) between the ages of 12 and 18 (mean age = 15.8 years; standard deviation = 1.3 years) who enrolled in a clinical trial comparing three behavioral treatments for adolescent marijuana abuse or dependence. Participants completed a delay discounting task at treatment onset for $100 and $1,000 of hypothetical money and marijuana. Overall, smaller magnitude rewards were discounted more than larger magnitude rewards. Delay discounting rates were concurrently related to demographic variables (socioeconomic status, race). Delay discounting of $1,000 of money predicted during treatment abstinence outcomes among adolescent marijuana abusers, over and above the effects of type of treatment received. Teens who show higher levels of discounting of the future may be an important subgroup to identify at treatment onset. Youth with a greater tendency to discount the future may require different intervention strategies that address their impulsivity (e.g., targeting executive function or inhibitory control) and/or different schedules of reinforcement to address their degree of preference for immediate rewards.

Delay discounting rates are predictive of drug use status, the likelihood of becoming abstinent, and a variety of health behaviors. Rates of delay discounting may also be related to other relevant behaviors associated with addiction, such as the frequency at which individuals redeem contingency management voucher earnings. This study examined the discounting rates of 152 participants in a buprenorphine treatment program for opioid abuse. Participants received up to 12 weeks of buprenorphine treatment combined with contingency management. Participant's drug use was measured via urine specimens submitted three times a week. Successive negative urine specimens were reinforced with increasing amounts of money. After each negative urine specimen, a participant could either redeem his or her earnings or accumulate it in an account. Analysis of the frequency of redemptions showed that participants with higher rates of delay discounting at study intake redeemed their earnings significantly more often than participants with lower rates of discounting. Age and income also predicted redemption rates. We suggest that delay discounting rates can be used to predict redemption behaviors in a contingency management treatment program and that these findings are consistent with the recent theory of the competing neurobehavioral decision systems., (PsycINFO Database Record (c) 2010 APA, all rights reserved.)

A typical temporal discounting procedure determines the present, subjective value (indifference point) of a delayed outcome at 5 to 8 different delays to that outcome. These indifference points are used to determine a single index of discounting called a discounting rate. One concern that remains in the collection of this data is the high number of trials or choices, resulting in participant fatigue or other factors that may affect the validity of the data. In this report, we propose an abbreviated alternative to the more comprehensive and time-consuming discounting procedure. Specifically, we propose that fewer indifference points can be used to determine statistically equivalent discount rates with no loss in data sensitivity. We reanalyzed temporal discounting data obtained with 7 indifference points, and estimated discount rates from all combinations of 2, 3, and 4 of the 7 indifference points. Results indicate that valid and sensitive discounting indices can be obtained with fewer indifference points, and the most appropriate sets of indifference points are highlighted. The proposed abbreviated procedure is likely to be particularly useful when time constraints or participant fatigue is a concern as well as in repeated-measures contexts., (PsycINFO Database Record 2010 APA, all rights reserved.)

Discounting, as a quantifiable measure of impulsivity, is often estimated within individuals via nonlinear regression. Here, we describe how to directly estimate within-individual change of the discounting parameter between 2 conditions and subsequently statistically test for that change using the discounting data from a single individual. To date, there has been no systematic description of how to conduct such an analysis. Employing the method allows investigators and clinicians to evaluate whether a single individual has statistically changed the way he or she discounts between 2 conditions (e.g., in the absence or presence of a pharmacologic, different time points, different rewards, etc.). We further describe a meta-analytic approach for combining estimated changes in discounting from individuals in a sample to make population inference. By providing more precise population estimates, this approach increases statistical power over traditional analytic methods., (2010 APA, all rights reserved)

During a 12-week intervention, opioid dependent participants (N = 120) maintained on thrice-a-week (M, W, F) buprenorphine plus therapist and computer-based counseling were randomized to receive: (a) medication contingencies (MC = thrice weekly dosing schedule vs. daily attendance and single-day 50% dose reduction imposed upon submission of an opioid and/or cocaine positive urine sample); (b) voucher contingency (VC = escalating schedule for opioid and/or cocaine negative samples with reset for drug-positive samples); or (c) standard care (SC), with no programmed consequences for urinalysis results. VC resulted in better 12-week retention (85%) compared to MC (58%; p = 0.009), but neither differed from SC (76% retained). After adjusting for baseline differences in employment, and compared to SC, the MC group achieved 1.5 more continuous weeks of combined opioid/cocaine abstinence (p = 0.030), while the VC group had 2 more total weeks of abstinence (p = 0.048). Drug use results suggest that both the interventions were efficacious, with effects primarily in opioid rather than cocaine test results. Findings should be interpreted in light of the greater attrition associated with medication-based contingencies versus the greater monetary costs of voucher-based contingencies., (2009 APA, all rights reserved.)